Clinical Trial

Songling Xuemaikang in Hypertension and Insomnia Evaluation（SHINE）

Name: Songling Xuemaikang in Hypertension and Insomnia Evaluation（SHINE） — clinical trial record (NCT07709442)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: SHINE

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

To evaluate the effect of Songling Xuemaikang Capsules on reducing 24-hour mean blood pressure in patients with hypertension accompanied by insomnia.

Trial Details

NCT Number	NCT07709442
Lead Sponsor	Jing Liu Collaborators: Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Conditions	Hypertension
Enrollment	260 participants
Start Date	2026-06-30
Primary Completion	2027-06-30 (estimated)
Study Completion	2028-04-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-16